/
Oncology
Neoplasm Metastasis
7
Pipeline Programs↗
2
Active Trials↗
5
Companies Involved↗
Neoplasm Metastasis is an early-stage landscape with 7 programs across 5 companies. The most active players are Boehringer Ingelheim.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 11
Phase 26
Phase 3
No programs
Approved
No programs
Analysis
Modality Breakdown
7programs
Small molecule343%
Monoclonal antibody343%
Antibody–drug conjugate114%
Modality classified for 100% of 7 pipeline programs.
Analysis
Trial Status
3
clinical trials
Active, not recruiting2 · 67%
Completed1 · 33%
Clinical Trials
Trial Activity
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)